Feedback on cancer drugs from people affected by cancer and clinicians
The Canadian Cancer Society is dedicated to improving the lives of people with cancer. We collect feedback about cancer drugs from people with cancer, their caregivers, and clinicians as part of this effort. This feedback helps shape recommendations for which drugs are covered under provincial and territorial drug plans.
We share your feedback with two organizations. Canada’s Drug Agency (CDA) is an independent, not-for-profit organization. It provides evidence and recommendations about medical procedures, devices and drugs (among other things) to healthcare decision-makers. The National Institute of Excellence in Health and Social Services (INESSS) promotes best practices and the efficient use of resources for health and social services. To ensure adequate representation across the cancer continuum, we will be focusing primarily on rare cancers and those that do not have representation through another organization.People with cancer and their caregivers
We want to hear from people living with and beyond cancer, as well as their caregivers. They have first-hand knowledge of life with cancer. Their experience means they can give us valuable feedback about the benefits and drawbacks of current treatments. They can also help assess new treatments.
Clinicians
The Canadian Cancer Society gathers feedback from clinicians on open calls and draft recommendations posted by CDA and INESSS. Clinician feedback helps these organizations make recommendations to healthcare decision makers that maximize the use of limited resources and enhance the quality of drug reviews.
Past submissions
To view submissions that have been made to CDA, including those made by CCS, please visit CDA’s Reimbursement Review Reports. (Note that it takes time for the submissions to be posted to this site, so you may need to check back to find the results of a specific CCS submission.)